Vectorious Medical Technologies

Vectorious Medical Technologies
Vectorious Medical Technologies developed the V-LAP, the world's first in-heart microcomputer for optimal heart disease treatment.
About
What does Vectorious Medical Technologies do?
Vectorious Medical Technologies is a medical device company that has developed the V-LAP, a miniature, wireless, battery-less, digital sensory implant designed to be placed in the heart. This in-heart microcomputer aims to provide continuous, direct left atrial pressure monitoring, enabling personalized and optimal treatment for heart disease patients, thereby improving their quality of life and life expectancy.
What is Vectorious Medical Technologies's revenue?
StartupHub estimates Vectorious Medical Technologies's annual revenue at $21.2M (range $11.8M to $32.6M, 66% confidence), based on comparable companies in the sector.
What is Vectorious Medical Technologies's valuation?
StartupHub estimates Vectorious Medical Technologies's effective valuation at $59.7M (range $36.3M to $87.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Vectorious Medical Technologies raised?
Vectorious Medical Technologies has raised a total of $15M in funding. The most recent round on record is Grant.
Where is Vectorious Medical Technologies headquartered?
Vectorious Medical Technologies is headquartered in Tel Aviv, Israel.
When was Vectorious Medical Technologies founded?
Vectorious Medical Technologies was founded in 2011.
What industry does Vectorious Medical Technologies operate in?
Vectorious Medical Technologies operates in Healthcare, Cardiology, Sensor, Heart Failure, MedTech, Medical Devices.
How many employees does Vectorious Medical Technologies have?
Vectorious Medical Technologies has approximately 114 people on record.
No comments yet. Be the first to share your take.
